Finance

Diamond Hill Capital's Small Cap Strategy has recently identified Knowles Corporation (KN) as a compelling new investment, highlighting its robust business model and strategic market positioning. The company, a specialized electronic components manufacturer, has demonstrated impressive financial performance, with its shares gaining nearly 100% over the past year. This strategic addition to the portfolio underscores a belief in Knowles' long-term growth potential, particularly given its focus on high-margin, mission-critical sectors within the medical, defense, and industrial markets. Despite a volatile market landscape influenced by geopolitical tensions, Knowles' resilience and strategic initiatives have positioned it as a noteworthy opportunity for investors seeking durable growth.

In the first quarter of 2026, Diamond Hill Capital's Small Cap Strategy unveiled its latest investor letter, where Knowles Corporation (NYSE:KN) was introduced as a newly acquired holding. Knowles Corporation, known for its expertise in specialized electronic components, manufactures a diverse range of products including capacitors, radio frequency (RF) and microwave filters, balanced armature speakers, and advanced medtech microphones. This strategic shift towards higher-margin, mission-critical end markets, particularly in medical, defense, and industrial applications, is seen as a pivotal factor in enhancing the company's long-term growth prospects and profitability.

As of May 4, 2026, Knowles Corporation's stock closed at $31.93 per share, showcasing a robust one-month return of 20.40%. Over the past 52 weeks, the company's shares have surged by an impressive 97.71%, indicating strong investor confidence and market momentum. With a current market capitalization of $2.73 billion, Knowles is demonstrating significant financial health and growth. The investment by Diamond Hill Capital reflects a conviction that the company's current valuation does not fully account for its improved business mix and the sustainable demand drivers within its targeted markets. This perspective suggests that Knowles is poised for further appreciation as its strategic reorientation continues to yield positive results.

The company's recent performance further substantiates its potential. In Q1 2026, Knowles Corporation reported revenues of $153 million, marking a substantial 16% year-over-year increase. This growth is a testament to its successful strategic initiatives and its ability to capture opportunities in specialized markets. While Knowles Corporation is not among the top 40 most popular stocks among hedge funds, its inclusion in Diamond Hill's portfolio signals a growing recognition of its underlying value. The hedge fund community has shown increasing interest, with the number of hedge fund portfolios holding Knowles Corporation rising from 21 to 30 by the end of the fourth quarter. This trend indicates a positive outlook from institutional investors, who are increasingly acknowledging the company's strategic strengths and future potential.

Knowles Corporation is strategically positioned for sustained growth due to its focused approach on specialized, high-demand electronic components. The company's recent initiatives to reconfigure its product portfolio have successfully steered it towards sectors with more resilient demand, such as medical, defense, and industrial markets. This deliberate pivot ensures that Knowles is less susceptible to broader market fluctuations and more aligned with long-term technological and industry trends. The strong financial performance, as evidenced by its substantial stock gains and revenue growth, confirms the effectiveness of these strategic adjustments. Investors are recognizing the intrinsic value and future potential embedded in Knowles' refined business model.

Health Savings Accounts (HSAs) serve as a crucial financial instrument for individuals with high-deductible health plans (HDHPs), allowing them to set aside funds for various medical expenditures. These accounts boast a distinctive "triple tax advantage": contributions are tax-deductible, investments within the account grow without being taxed, and withdrawals for qualifying medical costs are also tax-exempt. This makes HSAs an attractive option for managing healthcare finances and potentially supplementing retirement savings.

To qualify for an HSA, individuals must be covered by an HDHP and meet specific IRS criteria, including not having other health coverage, not being enrolled in Medicare, and not being claimed as a dependent. The IRS sets annual contribution limits, which for 2024 are $4,150 for individuals and $8,300 for families, with additional catch-up contributions allowed for those aged 55 and over. These limits encompass contributions from both individuals and employers, highlighting the collaborative aspect of funding these accounts.

HSAs offer a distinct advantage over other health savings options, such as Flexible Spending Accounts (FSAs), due to their flexibility and portability. Unlike FSAs, HSA funds roll over year-to-year, and account holders can take their HSA with them if they change employment. Furthermore, the ability to invest HSA funds in stocks and other securities allows for potential long-term growth, which can be particularly beneficial for future medical expenses or even as a retirement savings vehicle, especially after age 65 when non-qualified withdrawals are no longer subject to a penalty.

While HSAs present numerous benefits, they also come with important considerations. The requirement to pair an HSA with an HDHP means individuals must be comfortable with higher deductibles, which can be substantial (e.g., $1,600 for individuals and $3,200 for families in 2024). This structure may necessitate having sufficient cash reserves to cover initial out-of-pocket expenses before the HDHP coverage begins. Additionally, maintaining proper records for contributions and withdrawals is essential to comply with IRS regulations and avoid penalties for non-qualified distributions.

Withdrawals from an HSA are tax-free when used for a wide range of qualified medical expenses, including doctor visits, prescriptions, dental care, and vision care. However, insurance premiums generally do not count as qualified medical expenses, with exceptions for Medicare premiums, COBRA continuation coverage, and long-term care insurance within specified limits. Non-qualified withdrawals made before age 65 are subject to income tax and a 20% penalty, emphasizing the importance of using these funds for their intended purpose. After age 65, the penalty is waived, allowing greater flexibility in using HSA funds, albeit still subject to income tax for non-qualified uses.

Ultimately, HSAs offer a powerful tool for health and financial planning. Their unique tax benefits, combined with the ability to roll over funds and invest for growth, make them an attractive option for those seeking to mitigate the rising costs of healthcare, particularly as individuals approach retirement. The strategic use of an HSA can contribute significantly to long-term financial well-being by providing a dedicated, tax-advantaged source for medical expenses throughout various life stages.